Extended Data Fig. 6: Levels of BA metabolites detected in the PRISM cohort.
From: Human gut bacteria produce ΤΗ17-modulating bile acid metabolites

Abundances of identifiable BAs in PRISM cohort. BA levels were not universally decreased in CD patients, indicating that decreased levels of LCA, 3-oxoLCA, and isoLCA were not due to lower levels of all BAs in these cohorts. Boxplots show median and lower/upper quartiles with outliers outside of boxplot ‘whiskers’ (indicating the inner fences of the data). n = 34 for CD, n = 52 for UC and n = 34 for non-IBD. The percentage of zeros in each condition are added as x-axis tick labels. See Table S6 for full results.